Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CORCORAN A. C., MOORE P. J., TAYLOR R. D. Incidence of coexistent essential hypertension and malignant neoplastic diseases; study based on records of 509 clinic patients with and 509 without malignant neoplasms. Am J Med Sci. 1956 Nov;232(5):555–559. doi: 10.1097/00000441-195611000-00008. [DOI] [PubMed] [Google Scholar]
- FOLDES E. Cancer and cardiovascular diseases. N Y State J Med. 1949 Nov 1;49(21):2563–2565. [PubMed] [Google Scholar]
- MAINLAND D. The risk of fallacious conclusions from autopsy data on the incidence of diseases with applications to heart disease. Am Heart J. 1953 May;45(5):644–654. doi: 10.1016/0002-8703(53)90306-8. [DOI] [PubMed] [Google Scholar]
- PELLANDA E. B. LOW BLOOD PRESSURE AND CANCER. Folha Med. 1964 May;48:243–261. [PubMed] [Google Scholar]
- ZONDEK S. G. Inhibiting influence of essential hypertension on malignant growth and rheumatoid arthritis. Acta Med Scand. 1955 Oct 12;152(3):231–238. doi: 10.1111/j.0954-6820.1955.tb03482.x. [DOI] [PubMed] [Google Scholar]
- ZONDEK S. G., TCHETCHIK M. Malignant growths (including leukaemia) and essential hypertension. Br J Cancer. 1953 Dec;7(4):418–422. doi: 10.1038/bjc.1953.40. [DOI] [PMC free article] [PubMed] [Google Scholar]